Epidemiologic and microbiologic characteristics of recurrent bacterial and fungal meningitis in the Netherlands, 1988-2005

Clinical Infectious Diseases

Volumn 47, Issue 5, 2008, Pages

  Van Driel, Joris J ^a,b   Bekker, Vincent ^a   Spanjaard, Lodewijk ^b   Van Der Ende, Arie ^b   Kuijpers, Taco W ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MENINGITIS VACCINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BACTERIAL MENINGITIS; CHILD; FEMALE; FUNGAL MENINGITIS; HAEMOPHILUS INFLUENZAE TYPE B; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; NEISSERIA MENINGITIDIS; NETHERLANDS; PREVALENCE; PRIORITY JOURNAL; RECURRENT INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HAEMOPHILUS INFLUENZAE; HUMANS; INFANT; MALE; MENINGITIS, BACTERIAL; MENINGITIS, FUNGAL; MIDDLE AGED; NEISSERIA MENINGITIDIS; NETHERLANDS; PROSPECTIVE STUDIES; RECURRENCE; STREPTOCOCCUS PNEUMONIAE; YOUNG ADULT;

EID: 49449092808     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/590251     Document Type: Article

References (50)

1. Saez-Llorens X, McCracken GH Jr. Bacterial meningitis in children. Lancet 2003; 361:2139-48.
2. van de Beek D, de Gans J, Tunkel AR, Wijdicks EF. Community-acquired bacterial meningitis in adults. N Engl J Med 2006; 354:44-53.
3. Smith RJ, Bale J, White KR. Sensorineural hearing loss in children. Lancet 2005; 365:879-90.
4. van Alphen L, Spanjaard L, van der Ende A, Dankert J. Predicted disappearance of Haemophilus influenzae type b meningitis in Netherlands. Lancet 1994; 344:195.
5. van Alphen L, Spanjaard L, van der Ende A, Schuurman I, Dankert J. Effect of nationwide vaccination of 3-month-old infants in The Netherlands with conjugate Haemophilus influenzae type b vaccine: high efficacy and lack of herd immunity. J Pediatr 1997; 131:869-73.
6. de Greeff SC, de Melker HE, Spanjaard L, Schouls LM, van der Ende A. Protection from routine vaccination at the age of 14 months with meningococcal serogroup C conjugate vaccine in the Netherlands. Pediatr Infect Dis J 2006; 25:79-80.
7. Black S, Shinefield H. Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from northern California. Eur J Pediatr 2002; 161:127-31.
8. Ku CL, Picard C, Erdos M, et al. IRAK4 and NEMO mutations in otherwise healthy children with recurrent invasive pneumococcal disease. J Med Genet 2007; 44:16-23.
9. Mason EO Jr, Wald ER, Tan T, et al. Recurrent systemic pneumococcal disease in children. Pediatr Infect Dis J 2007; 26:480-4.
10. Armstrong D, Wong B. Central nervous system infections in immunocompromised hosts. Annu Rev Med 1982; 33:293-308.
11. Drummond DS, de Jong AL, Giannoni C, Sulek M, Friedman EM. Recurrent meningitis in the pediatric patient - the otolaryngologist's role. Int J Pediatr Otorhinolaryngol 1999; 48:199-208.
12. Grau I, Pallares R, Tubau F, et al.; Spanish Pneumococcal Infection Study Network (G03/103). Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med 2005; 165:1533-40.
13. Hung JJ, Ou LS, Lee WI, Huang JL. Central nervous system infections in patients with systemic lupus erythematosus. J Rheumatol 2005; 32:40-3.
14. Overturf GD. Indications for the immunological evaluation of patients with meningitis. Clin Infect Dis 2003; 36:189-94.
15. Picard C, Puel A, Bustamante J, Ku CL, Casanova JL. Primary immunodeficiencies associated with pneumococcal disease. Curr Opin Allergy Clin Immunol 2003; 3:451-9.
16. Theodoridou MN, Vasilopoulou VA, Atsali EE, et al. Meningitis registry of hospitalized cases in children: epidemiological patterns of acute bacterial meningitis throughout a 32-year period. BMC Infect Dis 2007; 7:101.
17. van de Beek D, De Gans J, Spanjaard L, Weisfelt M, Reitsma J, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med 2004; 351:1849-59.
18. Mulder CJ, Zanen HC. A study of 280 cases of neonatal meningitis in the Netherlands. J Infect 1984; 9:177-84.
19. Spanjaard L, Bol P, Zanen HC. Non-neonatal meningitis due to less common bacterial pathogens, the Netherlands, 1975-83. J Hyg (Lond) 1986; 97:219-28.
20. Statline Webversion. Available at: http://statline.cbs.nl/StatWeb/ publication/?DM=SLNL&PA=7052_95&D1=0,66,79,82&D2=0&D3=a&D4= 29-38&HDR=G1,G2,G3&STB=T&VW=T. Accessed 15 September 2006.
21. Klugman KP, Madhi SA, Feldman C. HIV and pneumococcal disease. Curr Opin Infect Dis 2007; 20:11-5.
22. Nuorti JP, Butler JC, Gelling L, Kool JL, Reingold AL, Vugia DJ. Epidemiologic relation between HIV and invasive pneumococcal disease in San Francisco County, California. Ann Intern Med 2000; 132:182-90.
23. Hosoglu S, Ayaz C, Ceviz A, Cumen B, Geyik MF, Kokoglu OF. Recurrent bacterial meningitis: a 6-year-old experience in adult patients. J Infect 1997; 35:55-62.
24. Lieb G, Krauss J, Collmann H, Schrod L, Sorensen N. Recurrent bacterial meningitis. Eur J Pediatr 1996; 155:26-30.
25. Durand ML, Calderwood SB, Weber DJ, et al. Acute bacterial meningitis in adults: a review of 493 episodes. N Engl J Med 1993; 328:21-8.
26. Pappas DG, Hammerschlag PE Jr, Hammerschlag M. Cerebrospinal fluid rhinorrhea and recurrent meningitis. Clin Infect Dis 1993; 17:364-8.
27. Korinek AM, Baugnon T, Golmard JL, van Effenterre R, Coriat P, Puybasset L. Risk factors for adult nosocomial meningitis after craniotomy: role of antibiotic prophylaxis. Neurosurgery 2006; 59:126-33.
28. Einarsdottir HM, Erlendsdottir H, Kristinsson KG, Gottfredsson M. Nationwide study of recurrent invasive pneumococcal infections in a population with a low prevalence of human immunodeficiency virus infection. Clin Microbiol Infect 2005; 11:744-9.
29. + T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci USA 2005; 102:4848-53.
30. Castigli E, Geha RS. Molecular basis of common variable immunodeficiency. J Allergy Clin Immunol 2006; 117:740-6.
31. Kleinschek MA, Muller U, Brodie SJ, et al. IL-23 enhances the inflammatory cell response in Cryptococcus neoformans infection and induces a cytokine pattern distinct from IL-12. J Immunol 2006; 176:1098-106.
32. Redd SC, Rutherford GW III, Sande MA, et al. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents. J Infect Dis 1990; 162:1012-7.
33. Salzer U, Grimbacher B. Monogenetic defects in common variable immunodeficiency: what can we learn about terminal B cell differentiation? Curr Opin Rheumatol 2006; 18:377-82.
34. Huang SS, Platt R, Rifas-Shiman SL, Pelton SI, Goldmann D, Finkelstein JA. Post-PCV7 changes in colonizing pneumococcal serotypes in 16 Massachusetts communities, 2001 and 2004. Pediatrics 2005; 116:e408-13.
35. Kaplan SL, Mason EO Jr, Wald ER, et al. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine. Pediatrics 2004; 113:443-9.
36. Kyaw MH, Lynfield R, Schaffner W, et al.; Active Bacterial Core Surveillance of the Emerging Infections Program Network. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae. N Engl J Med 2006; 354:1455-63.
37. McEllistrem MC, Mendelsohn AB, Pass MA, et al. Recurrent invasive pneumococcal disease in individuals with human immunodeficiency virus infection. J Infect Dis 2002; 185:1364-8.
38. Poehling KA, Talbot TR, Griffin MR, et al. Invasive pneumococcal disease among infants before and after introduction of pneumococcal conjugate vaccine. JAMA 2006; 295:1668-74.
39. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993; 269:221-6.
40. Barbour ML, Mayon-White RT, Coles C, Crook DWM, Moxon ER. The impact of conjugate vaccine on carriage of Haemophilus influenzae type b. J Infect Dis 1995; 171:93-8.
41. Finkelstein JA, Huang SS, Daniel J, et al. Antibiotic-resistant Streptococcus pneumoniae in the heptavalent pneumococcal conjugate vaccine era: predictors of carriage in a multicommunity sample. Pediatrics 2003; 112:862-9.
42. Klugman KP, Madhi SA, Huebner RE, Kohberger R, Mbelle N, Pierce N; Vaccine Trialists Group. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 2003; 349:1341-8.
43. Lexau CA, Lynfield R, Danila R, et al.; Active Bacterial Core Surveillance Team. Changing epidemiology of invasive pneumococcal disease among older adults in the era of pediatric pneumococcal conjugate vaccine. JAMA 2005; 294:2043-51.
44. French N, Moore M, Haikala R, Kayhty H, Gilks CF. A case-control study to investigate serological correlates of clinical failure of 23-valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults. J Infect Dis 2004; 190:707-12.
45. Netherlands Reference Laboratory for Bacterial Meningitis. Bacterial meningitis in the Netherlands: annual report 2006. Amsterdam: Netherlands Reference Laboratory for Bacterial Meningitis, 2007.
46. Fickweiler K, Borte M, Fasshauer M, Spencker FB, Handerick W, Rodloff AC. Meningitis due to Haemophilus influenzae type f in an 8-year old girl with congenital humoral immunodeficiency. Infection 2004; 32:112-5.
47. Fijen CA, Kuijper EJ, te Bulte MT, Daha MR, Dankert J. Assessment of complement deficiency in patients with meningococcal disease in The Netherlands. Clin Infect Dis 1999; 28:98-105.
48. Sjoholm AG, Jonsson G, Braconier JH, Sturfelt G, Truedsson L. Complement deficiency and disease: an update. Mol Immunol 2006; 43:78-85.
49. van den Bogaard R, Fijen CA, Schipper MG, de Galan L, Kuijper EJ, Mannens MM. Molecular characterisation of 10 Dutch properdin type I deficient families: mutation analysis and X-inactivation studies. Eur J Hum Genet 2000; 8:513-8.
50. Fijen CA, van der Ende A, Kuijpers T. Familial complement deficiencies in bacterial meningitis. Amsterdam: University of Amsterdam, 2006.